Name
OÜ MediTrials
Registry code
12662918
VAT number
EE102052448
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
19.05.2014 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
72191 - Other research and experimental development on natural sciences and engineering
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Mart Kull 08.09.1981 (43) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| 2019 06.11.2022 | 2020 26.11.2023 | 2021 09.12.2023 | 2022 09.12.2023 | |
|---|---|---|---|---|
| Total Revenue | 365 359 € | 424 140 € | 464 930 € | 511 732 € |
| Net profit (loss) for the period | 38 061 € | 88 074 € | 108 573 € | 103 735 € |
| Profit Margin | 10% | 21% | 23% | 20% |
| Current Assets | 296 729 € | 362 354 € | 446 150 € | 530 282 € |
| Fixed Assets | 39 356 € | 33 666 € | 27 976 € | 22 286 € |
| Total Assets | 336 085 € | 396 020 € | 474 126 € | 552 568 € |
| Current Liabilities | 22 087 € | 23 949 € | 33 982 € | 17 719 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 313 998 € | 372 071 € | 440 144 € | 534 849 € |
| Employees | 6 | 6 | 6 | 7 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 168 547.75 € | 32 253.37 € | 32 158.51 € | 18 |
| 2023 Q4 | 240 681.15 € | 64 920.46 € | 36 679.28 € | 19 |
| 2023 Q3 | 208 805.96 € | 42 914.89 € | 33 708.69 € | 18 |
| 2023 Q2 | 46 238.32 € | 93 134.01 € | 27 705.08 € | 18 |
| 2023 Q1 | 177 911.38 € | 34 740.45 € | 35 358.96 € | 19 |
| 2022 Q4 | 105 518.72 € | 41 314.42 € | 31 357.94 € | 18 |
| 2022 Q3 | 81 534.3 € | 37 909.31 € | 32 299.53 € | 16 |
| 2022 Q2 | 55 904.17 € | 22 609.74 € | 23 549.31 € | 14 |
| 2022 Q1 | 93 648.43 € | 46 904.75 € | 31 095.99 € | 13 |
| 2021 Q4 | 73 269.3 € | 24 816.03 € | 17 590.78 € | 14 |
| 2021 Q3 | 108 708.84 € | 41 624.93 € | 27 812.68 € | 12 |
| 2021 Q2 | 79 939.39 € | 37 948.03 € | 28 283.65 € | 12 |
| 2021 Q1 | - | 27 813.27 € | 29 797.35 € | 11 |
| 2020 Q4 | 102 111 € | 24 349.62 € | 26 120.95 € | 11 |
| 2020 Q3 | 162 092.05 € | 36 624.84 € | 14 425.94 € | 11 |
| 2020 Q2 | 29 794.64 € | 26 876.72 € | 26 140.71 € | 11 |
| 2020 Q1 | 38 114.2 € | 42 591.16 € | 23 584.84 € | 10 |
